Immune to Cancer: The CRI Blog
-
Recent Innovations and Challenges in Fighting Blood Cancers
The term “blood cancer” encompasses several types of cancer, including leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes (MDS),… -
A CRI Board Member’s Father was Diagnosed with Cancer – He Quickly Raised Over $150,000 for Research
It started with an idea. Yacov Arnopolin wanted to raise money for a cause that was close… -
Dr. Jill O’Donnell-Tormey Discusses the Latest Developments in Immunological Technologies
CRI’s CEO and Director of Scientific Affairs, Dr. Jill O’Donnell-Tormey, recently spoke with ecancer about recent developments… -
Sarcomas: Unique Cancers that Merit Further Attention and Research
Sarcomas are unique compared to other types of cancer variations. In contrast to carcinomas, which arise from… -
CRI’s Wear White Luncheon Raises Over $30,000
By Rebecca Jensen The Cancer Research Institute held its fourth annual Wear White Luncheon, hosted by Mary… -
Why Do We Get Cancer? How Our Lifestyles Impact Our Risk
There are many factors that dictate whether someone will develop cancer, and they fall roughly into two… -
ASCO 2023 Preview — Partnering with Patients: The Cornerstone of Cancer Care and Research
This weekend, the highly anticipated 2023 annual meeting of the American Society of Clinical Oncologists (ASCO) takes… -
<strong><u>AACR 2023 Recap: CRI Scientists Tackle the Frontiers of Cancer Immunotherapy</u></strong>
More than any conference yet, the 2023 annual meeting of the American Association for Cancer Research (AACR… -
<strong>E. John Wherry, PhD, Receives 2023 AACR-CRI Lloyd J. Old Award in Cancer Immunology</strong>
E. John Wherry, PhD — the director of the Institute for Immunology, chair of the Department of…